The owners of over a dozen New York-area pharmacies were charged in an indictment unsealed today for their roles in a $30 million health care fraud and money laundering scheme, in which they exploited emergency codes and edits in the Medicare system that went into effect due to the COVID-19 pandemic in order to submit
MoreLast week, the U.S. Department of Labor took a range of actions to aid American workers and employers as our nation combats the coronavirus pandemic.
MoreSARS-CoV-2 Variant – United Kingdom
Published on
On 14 December 2020, authorities of the United Kingdom (UK) reported to WHO that a new SARS-CoV-2 variant was identified through viral genomic sequencing.
MoreFollowing a request for assistance from Serbia, the EU is sending 500,000 FFP2 and FFP3 protective facemasks, 540,000 medical gloves, 49,200 protective overalls, 49,200 cover shoes for overalls, and 5,500 goggles from the rescEU medical equipment reserve hosted in Greece.
MoreFifteen House Republicans are seeking a briefing with Georgia Secretary of State Brad Raffensperger over suspected election irregularities in the state.
MoreAttacks by armed groups in Mozambique’s Cabo Delgado, Nampula, Zambezia and Niassa provinces have displaced more than 530,000 people, many of whom have been forced to move multiple times, the UN refugee agency (UNHCR) said on Friday.
MoreWith a week to go until elections are scheduled to take place in the Central African Republic (CAR), the UN is concerned about an escalation of armed attacks, amid reports that armed groups have taken control of towns near the capital, Bangui.
MoreMarks and Spencer Group plc ("M&S") is providing this notification following the grant of conditional share awards under the Company's Performance Share Plan on 6 July 2020 ("2020 PSP Award").
MoreCommencement of the Drilling of Perseverance #1
Published on
Perseverance #1 is targeting P50 prospective oil resources of 0.77 billion barrels, with an upside of 1.44 billion barrels
MoreLicense Agreement with Astrea Bioseparations
Published on
Avacta Group plc (AIM: AVCT), the developer of innovative cancer therapies and diagnostics based on its proprietary Affimer® and pre|CISIONTM platforms, is pleased to announce that it has entered into a license agreement with Astrea Bioseparations ("Astrea") for the use of the Affimer platform in affinity purification applications.
More